Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia

Emerging Infectious Diseases

Volumn 20, Issue 8, 2014, Pages 1280-1286

  Alifrangis, Michael ^a,b   Nag, Sidsel ^a,b   Schousboe, Mette L ^a,b   Ishengoma, Deus ^c   Lusingu, John ^c   Pota, Hirva ^d   Kavishe, Reginald A ^e,f   Pearce, Richard ^d   Ord, Rosalynn ^d   Lynch, Caroline ^d   Dejene, Seyoum ^g   Cox, Jonathan ^d   Rwakimari, John ^h   Minja, Daniel T R ^c   Lemnge, Martha M ^c   Roper, Cally ^d  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Rigshospitalet   (Denmark)

^c Tanga Research Centre   (Tanzania)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KILIMANJARO CHRISTIAN MEDICAL UNIVERSITY COLLEGE   (Tanzania)

^f KILIMANJARO CLINICAL RESEARCH INSTITUTE   (Tanzania)

^g MÉDECINS SANS FRONTIÈRES   (Switzerland)

^h MINISTRY OF HEALTH   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

FOLIC ACID ANTAGONIST; MICROSATELLITE DNA; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE;

ADOLESCENT; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CHILD; ETHIOPIA; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HUMAN; MAJOR CLINICAL STUDY; MALARIA; MUTATION; PLASMODIUM FALCIPARUM; POINT MUTATION; PRESCHOOL CHILD; TANZANIA; UGANDA; ALLELE; DRUG EFFECTS; DRUG RESISTANCE; GENE FREQUENCY; GENETICS; HAPLOTYPE; INFANT; MALARIA, FALCIPARUM; PARASITOLOGY; YOUNG ADULT;

ADOLESCENT; ALLELES; CHILD; CHILD, PRESCHOOL; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; ETHIOPIA; FOLIC ACID ANTAGONISTS; GENE FREQUENCY; HAPLOTYPES; HUMANS; INFANT; MALARIA, FALCIPARUM; MICROSATELLITE REPEATS; MUTATION; PLASMODIUM FALCIPARUM; TANZANIA; TETRAHYDROFOLATE DEHYDROGENASE; UGANDA; YOUNG ADULT;

EID: 84905243669     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2008.131897     Document Type: Article

References (39)

1. World Health Organization. World malaria report 2012 [cited 2014 May 23]. http://www.who.int/malaria/publications/world_malaria_report_2012/report/en/index.html
2. Aubouy A, Fievet N, Bertin G, Sagbo JC, Kossou H, Kinde-Gazard D, et al. Dramatically decreased therapeutic efficacy of chloroquine and sulfadoxine-pyrimethamine, but not mefloquine, in southern Benin. Trop Med Int Health. 2007;12:886-94. http://dx.doi.org/10.1111/j.1365-3156.2007.01859.x
3. Harinasuta T, Suntharasamai P, Viravan C. Chloroquineresistant falciparum malaria in Thailand. Lancet. 1965;2:657-60. http://dx.doi.org/10.1016/S0140-6736(65)90395-8
4. Trape JF, Pison G, Preziosi MP, Enel C, Desgrées du Loû A, Delaunay V, et al. Impact of chloroquine resistance on malaria mortality. C R Acad Sci III. 1998;321:689-97. http://dx.doi.org/10.1016/S0764-4469(98)80009-7
5. Talisuna AO, Bloland P, D'Alessandro U. History, dynamics, and public health importance of malaria parasite resistance. Clin Microbiol Rev. 2004;17:235-54. http://dx.doi.org/10.1128/CMR.17.1.235-254.2004
6. Verdrager J, Riche A, Chheang CM. Treatment of "P. falciparum" malaria by delayed-action sulfonamides [in French]. Presse Med. 1967;75:2839-40.
7. Roper C, Pearce R, Nair S, Sharp B, Nosten F, Anderson T. Intercontinental spread of pyrimethamine-resistant malaria. Science. 2004;305:1124. http://dx.doi.org/10.1126/science.1098876
8. Maïga O, Djimdé AA, Hubert V, Renard E, Aubouy A, Kironde F, et al. A shared Asian origin of the triple-mutant dhfr allele in Plasmodium falciparum from sites across Africa. J Infect Dis. 2007;196:165-72. http://dx.doi.org/10.1086/518512
9. Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, et al. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. J Infect Dis. 1997;176:1590-6. http://dx.doi.org/10.1086/514159
10. Pearce RJ, Pota H, Evehe MS, Bâel H, Mombo-Ngoma G, Malisa AL, et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med. 2009;6:e1000055. http://dx.doi.org/10.1371/journal.pmed.1000055
11. Gatton ML, Martin LB, Cheng Q. Evolution of resistance to sulfadoxine-pyrimethamine in Plasmodium falciparum. Antimicrob Agents Chemother. 2004;48:2116-23. http://dx.doi.org/10.1128/AAC.48.6.2116-2123.2004
12. Jelinek T, Ronn AM, Lemnge MM, Curtis J, Mhina J, Duraisingh MT, et al. Polymorphisms in the dihydrofolate reductase (DHFR) and dihydropteroate synthetase (DHPS) genes of Plasmodium falciparum and in vivo resistance to sulphadoxine/pyrimethamine in isolates from Tanzania. Trop Med Int Health. 1998;3:605-9. http://dx.doi.org/10.1046/j.1365-3156.1998.00280.x
13. World Health Organization. Guidelines for the treatment of malaria. 2nd ed. Geneva: The Organization; 2010 [cited 2014 May 23]. http://whqlibdoc.who.int/publications/2010/9789241547925_eng.pdf
14. World Health Organization. WHO policy recommendation on intermittent preventive treatment during infancy with sulphadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa. Geneva: The Organization; 2010 [cited 2014 May 23]. http://www.who.int/malaria/news/WHO_policy_recommendation_IPTi_032010.pdf
15. World Health Organization. Draft recommendations on intermittent preventive treatment in pregnancy. Geneva: The Organization; 2013 [cited 2014 May 23]. http://www.who.int/malaria/mpac/mpac_sep13_erg_ipt_malaria_pregnancy_report.pdf
16. World Health Organization. WHO policy recommendation: seasonal malaria chemoprevention (SMC) for Plasmodium falciparum malaria control in highly seasonal transmission areas of the Sahel sub-region in Africa. Geneva: The Organization; 2012 [cited 2014 May 23]. http://www.who.int/malaria/publications/atoz/smc_policy_recommendation_en_032012.pdf
17. Triglia T, Menting JG, Wilson C, Cowman AF. Mutations in dihydropteroate synthase are responsible for sulfone and sulfonamide resistance in Plasmodium falciparum. Proc Natl Acad Sci U S A. 1997;94:13944-9. http://dx.doi.org/10.1073/pnas.94.25.13944
18. Cowman AF, Morry MJ, Biggs BA, Cross GA, Foote SJ. Amino acid changes linked to pyrimethamine resistance in the dihydrofolate reductase-thymidylate synthase gene of Plasmodium falciparum. Proc Natl Acad Sci U S A. 1988;85:9109-13. http://dx.doi.org/10.1073/pnas.85.23.9109
19. Brooks DR, Wang P, Read M, Watkins WM, Sims PF, Hyde JE. Sequence variation of the hydroxymethyldihydropterin pyrophosphokinase: dihydropteroate synthase gene in lines of the human malaria parasite, Plasmodium falciparum, with differing resistance to sulfadoxine. Eur J Biochem. 1994;224:397-405. http://dx.doi.org/10.1111/j.1432-1033.1994.00397.x
20. Gosling RD, Gesase S, Mosha JF, Carneiro I, Hashim R, Lemnge M, et al. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2009;374:1521-32. http://dx.doi.org/10.1016/S0140-6736(09)60997-1
21. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, et al. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at codon 581. PLoS ONE. 2009;4:e4569. http://dx.doi.org/10.1371/journal.pone.0004569
22. Naidoo I, Roper C. Mapping "partially resistant", "fully resistant", and "super resistant" malaria. Trends Parasitol. 2013;29:505-15. http://dx.doi.org/10.1016/j.pt.2013.08.002
23. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, et al. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Proc Natl Acad Sci U S A. 2009;106:9027-32. http://dx.doi.org/10.1073/pnas.0901415106
24. Harrington WE, Morrison R, Fried M, Duffy PE. Intermittent preventive treatment in pregnant women is associated with increased risk of severe malaria in their offspring. PLoS ONE. 2013;8:e56183. http://dx.doi.org/10.1371/journal.pone.0056183
25. Minja DT, Schmiegelow C, Mmbando B, Boström S, Oesterholt M, Magistrado P, et al. Plasmodium falciparum mutant haplotype infection during pregnancy associated with reduced birthweight, Tanzania. Emerg Infect Dis. 2013;19:1446-54. http://dx.doi.org/10.3201/eid1909.130133
26. Alifrangis M, Lusingu JP, Mmbando B, Dalgaard MB, Vestergaard LS, Ishengoma D, et al. Five-year surveillance of molecular markers of Plasmodium falciparum antimalarial drug resistance in Korogwe District, Tanzania: accumulation of the 581G mutation in the P. falciparum dihydropteroate synthase gene. Am J Trop Med Hyg. 2009;80:523-7.
27. Lynch C, Pearce R, Pota H, Cox J, Abeku TA, Rwakimari J, et al. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J Infect Dis. 2008;197:1598-604. http://dx.doi.org/10.1086/587845
28. Karema C, Imwong M, Fanello CI, Stepniewska K, Uwimana A, Nakeesathit S, et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob Agents Chemother. 2010;54:477-83. http://dx.doi.org/10.1128/AAC.00498-09
29. Alker AP, Kazadi WM, Kutelemeni AK, Bloland PB, Tshefu AK, Meshnick SR. dhfr and dhps genotype and sulfadoxine-pyrimethamine treatment failure in children with falciparum malaria in the Democratic Republic of Congo. Trop Med Int Health. 2008;13:1384-91. http://dx.doi.org/10.1111/j.1365-3156.2008.02150.x
30. Spalding MD, Eyase FL, Akala HM, Bedno SA, Prigge ST, Coldren RL, et al. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya. Malar J. 2010;9:338. http://dx.doi.org/10.1186/1475-2875-9-338
31. Ishengoma DS, Mmbando BP, Segeja MD, Alifrangis M, Lemnge MM, Bygbjerg IC. Declining burden of malaria over two decades in a rural community of Muheza district, north-eastern Tanzania. Malar J. 2013;12:338. http://dx.doi.org/10.1186/1475-2875-12-338
32. Wooden J, Kyes S, Sibley CH. PCR and strain identification in Plasmodium falciparum. Parasitol Today. 1993;9:303-5. http://dx.doi.org/10.1016/0169-4758(93)90131-X
33. Alifrangis M, Enosse S, Pearce R, Drakeley C, Roper C, Khalil IF, et al. A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction-and enzyme-linked immunosorbent assay-based technology. Am J Trop Med Hyg. 2005;72:155-62.
34. Roper C, Pearce R, Bredenkamp B, Gumede J, Drakeley C, Mosha F, et al. Antifolate antimalarial resistance in southeast Africa: a population-based analysis. Lancet. 2003;361:1174-81. http://dx.doi.org/10.1016/S0140-6736(03)12951-0
35. Zeile I, Gahutu JB, Shyirambere C, Steininger C, Musemakweri A, Sebahungu F, et al. Molecular markers of Plasmodium falciparum drug resistance in southern highland Rwanda. Acta Trop. 2012;121:50-4. http://dx.doi.org/10.1016/j.actatropica.2011.09.009
36. Gadalla NB, Abdallah TM, Atwal S, Sutherland CJ, Adam I. Selection of pfdhfr/pfdhps alleles and declining artesunate/sulphadoxine- pyrimethamine efficacy against Plasmodium falciparum eight years after deployment in eastern Sudan. Malar J. 2013;12:255. http://dx.doi.org/10.1186/1475-2875-12-255
37. Iriemenam NC, Shah M, Gatei W, van Eijk AM, Ayisi J, Kariuki S, et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drugresistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar J. 2012;11:134. http://dx.doi.org/10.1186/1475-2875-11-134
38. Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, et al. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine- pyrimethamine (SP) resistance in eastern Sudan. Infect Genet Evol. 2009;9:778-83. http://dx.doi.org/10.1016/j.meegid.2009.04.010
39. Pindolia DK, Garcia AJ, Huang Z, Smith DL, Alegana VA, Noor AM, et al. The demographics of human and malaria movement and migration patterns in East Africa. Malar J. 2013;12:397. http://dx.doi.org/10.1186/1475-2875-12-397